[144] Doximity, Inc. SEC Filing

Rhea-AI Filing Summary

Doximity, Inc. (DOCS) insider filing notifies a proposed sale of 5,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $354,200.00, scheduled for 10/10/2025 on the NYSE. The shares were acquired the same day by stock option exercise and paid in cash. The filing also discloses three earlier sales by the same seller totaling 15,000 shares in 07/11/2025, 08/08/2025, and 09/12/2025 with gross proceeds of $300,200.00, $315,000.00, and $352,500.00 respectively.

The signer affirms they are unaware of undisclosed material adverse information and, by submitting Form 144, is complying with Rule 144 notification requirements for proposed resale of restricted or control securities.

Positive

• Timely compliance with Rule 144 by notifying a proposed sale of 5,000 shares
• Full disclosure of acquisition method (stock option exercise) and cash payment
• Broker and exchange identified (Morgan Stanley Smith Barney; NYSE) enabling transparent execution

Negative

• Ongoing insider selling evidenced by 15,000 shares sold in the prior three months
• Concentrated short-term disposals may signal continued insider liquidity needs over recent months

Insights

Insider Transactions Analyst

Insider exercised options and plans a sale of 5,000 shares on 10/10/2025.

The filing shows the 5,000 shares were acquired on 10/10/2025 via a stock option exercise with cash payment and are scheduled for sale through Morgan Stanley Smith Barney on the NYSE for an aggregate value of $354,200. This is routine for option holders who exercise and promptly sell to cover tax and cost basis.

Recent prior disposals total 15,000 shares across three dates in 07/11/2025, 08/08/2025, and 09/12/2025, indicating ongoing vesting-related or liquidity-driven sales. Monitor short-term insider liquidity patterns over the next 30-90 days for additional filings.

Compliance & Regulatory Specialist

Form 144 is a procedural disclosure to satisfy Rule 144 resale notice requirements.

The filer affirms the absence of undisclosed material adverse information and provides broker, share count, and aggregate value details required for compliance. The schedule and broker details (Morgan Stanley Smith Barney) align with standard resale channels for registered securities on the NYSE.

Watch for any related Form 4 or amended Form 144s within several days that would confirm execution or changes to the proposed sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	354200.00	187299459	10/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/10/2025	Stock Option Exercise	ISSUER			5000	10/10/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
REGINA M BENJAMIN 500 3rd Street Ste 510 San Francisco CA 94107	Common	09/12/2025	5000	352500.00
REGINA M BENJAMIN 500 3rd Street Ste 510 San Francisco CA 94107	Common	08/08/2025	5000	315000.00
REGINA M BENJAMIN 500 3rd Street Ste 510 San Francisco CA 94107	Common	07/11/2025	5000	300200.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for DOCS on 10/10/2025 disclose?

It discloses a proposed sale of 5,000 common shares with aggregate market value $354,200.00, acquired by stock option exercise and to be sold via Morgan Stanley Smith Barney on the NYSE on 10/10/2025.

Who is selling the DOCS shares and how were they acquired?

The filing indicates the shares were acquired by the selling person via a stock option exercise on 10/10/2025 and paid for in cash.

Has the same person sold DOCS shares recently?

Yes. The filing lists three prior sales totaling 15,000 shares on 07/11/2025, 08/08/2025, and 09/12/2025 with combined gross proceeds of $967,700.00.

Does this Form 144 confirm the sale has occurred?

No. Form 144 notifies a proposed sale under Rule 144. Execution would typically be confirmed later by a Form 4 or another filing.

Where will the proposed DOCS shares be sold?

The notice specifies the sale is planned on the NYSE through Morgan Stanley Smith Barney LLC.